Translocator Protein PET/CT in Various TSPO-Related Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorTianjin Medical University
About this trial
To evaluate the potential usefulness of 18F-DPA714/FDPA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various TSPO-related disease patients.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- 18F-DPA714/FDPA
Treatment groups
200 Participants
are divided into 1 treatment groupLocations
2The First Affiliated Hospital of University of Science and Technology of China230000, HefeiAnhui, China
Tianjin Medical University General Hospital300052, TianjinTianjin Municipality, China
Sponsors and collaborators
Tianjin Medical University
Lead sponsor
Tianjin Medical University General Hospital
Collaborator
Source ClinicalTrials.gov